HOME >> MEDICINE >> NEWS
NIH grant to fund U-Georgia's doctoral student's innovative dietary research

You'd better eat your veggies. University of Georgia researchers may be calling to check up on you.

A new $147,200 two-year federal grant from the National Institutes of Health will help researchers from UGA's College of Public Health understand how communication and lifestyles affect our consumption of fruits and vegetables.

Researchers will be developing long-term communication campaigns touting healthy dietary modifications at a time when cancer claims more than half a million lives each year. Lindsay J. Della, principal investigator and a doctoral candidate in Health Promotion and Behavior at UGA, said, "For nearly a decade and a half, the National Cancer Institute's nationally recognized communication program has informed Americans that eating five or more servings of fruit and vegetables can yield significant health benefits.

"But, according to the American Journal of Public Health, fruit and vegetable consumption has remained relatively stable from 1994 to the beginning of the 21st century," Della said. "New approaches need to be developed to provide more cost-effective health promotion methods that foster long-term dietary changes."

Della's study will attempt to identify whether a cross section of adults (males and females ages 18 to 74) living diverse lifestyles hold different attitudes toward their intake of fruit and vegetables. The knowledge gained through this study, in part, will help researchers understand how consumer marketing tools can be leveraged to augment the National Cancer Institute's current "5-A-Day" campaign.

Della's project co-investigators are David M. DeJoy, Ph.D., Director of the Workplace Health Group and Professor of Health Promotion and Behavior who will contribute scientific advice in health behavior research, and Charles E. Lance, Ph. D., Professor of Psychology, Applied Psychology Program, who will contribute expert advice during the analysis portion of the project.

The idea grew fr
'"/>

Contact: Kim Carlyle
kcarlyle@uga.edu
706-542-8083
University of Georgia
1-Nov-2005


Page: 1 2

Related medicine news :

1. Indiana University Imaging Center receives $6M grant for kidney research
2. New grant fulfills wish of late Baltimore Orioles team photographer
3. USC and Childrens Hospital Los Angeles both receive grants for stem cell facilities
4. Aussie research goes global through new grants
5. UIC awarded $7M NIH grant for infertility research
6. $2.6M grant awarded to New York University College of Nursing
7. $10M grant to VCU to develop new cancer treatments
8. Largest ever grant for University of Copenhagenhagen
9. $7.5 million NIH grant to Yale for Autism Center of Excellence
10. Tennessee researcher earns Komen grant to study depression and breast cancer
11. AIUM announced Endowment for Education and Research grant recipients

Post Your Comments:
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: